Nevro Corp (NYSE:NVRO)
| 168.20 Delayed Data As of Mar 02 |  +0.09 / +0.05%Today’s Change | 65.05 Today|||52-Week Range 188.14 | -2.83% Year-to-Date |
Latest NVRO News | Press Releases
| Nevro (NVRO) Q4 Loss Narrower Than Estimated, Revenues Miss Feb 25 / Zacks.com - Paid Partner Content | Nevro Corp (NVRO) Q4 2020 Earnings Call Transcript Feb 24 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 168.11 |
| Today’s open | 170.29 |
| Day’s range | 167.67 - 171.63 |
| Volume | 179,843 |
| Average volume (3 months) | 355,123 |
| Market cap | $5.7B |
Data as of 4:00pm ET, 03/02/2021
Growth & Valuation
| Earnings growth (last year) | +26.72% |
| Earnings growth (this year) | +10.05% |
| Earnings growth (next 5 years) | +13.00% |
| Revenue growth (last year) | -7.23% |
| P/E ratio | NM |
| Price/Sales | 16.10 |
| Price/Book | 14.55 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TNDMTandem Diabetes Care... | -2.29 | -2.39% |
| IRTCiRhythm Technologies... | -3.98 | -2.60% |
| LIVNLivaNova PLC | -0.51 | -0.66% |
| ---- |
Data as of 4:00pm ET, 03/02/2021
Financials
| Next reporting date | May 10, 2021 |
| EPS forecast (this quarter) | -$0.85 |
| Annual revenue (last year) | $362.0M |
| Annual profit (last year) | -$83.1M |
| Net profit margin | -22.94% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Redwood City, California |
Forecasts
